Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XZH | ISIN: FR0012882389 | Ticker-Symbol: PHF
Frankfurt
03.07.25 | 09:59
47,600 Euro
+2,70 % +1,250
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
EQUASENS SA Chart 1 Jahr
5-Tage-Chart
EQUASENS SA 5-Tage-Chart
RealtimeGeldBriefZeit
48,10048,35010:16

Aktuelle News zur EQUASENS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDividendenbekanntmachungen (02.07.2025)3.938 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AECOM  US00766T1007  0,26 USD  0,2202 EUR  AMADEUS IT GROUP SA  ES0109067019 - 0,89 EUR  ASSECO SOUTH EASTERN EUROPE SA  PLASSEE00014  1...
► Artikel lesen
DiEquasens: General meeting - Results of the votes58Villers-lès-Nancy, 1st July 2025 - 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares comprising...
► Artikel lesen
MoEquasens: acquisition of DIS and RESURGENCES BUSINESSES156Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE...
► Artikel lesen
EQUASENS Aktie jetzt für 0€ handeln
06.06.Equasens: availability of AGM preparatory materials1
12.05.Equasens: Q1 revenue at 31 March 2025306Villers-lès-Nancy, 12 May 2025 - 6:00 PM (CET) PRESS RELEASE Q1 revenue at 31 March 2025: €57.0m+ 6.9% growth on a reported basis and + 5.9% like-for-like Q1 2025 REVENUE (€m)2024Reported basis2025Reported...
► Artikel lesen
28.03.Equasens: 2024 annual results340Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment...
► Artikel lesen
06.03.Softwareanbieter: Von Prisma/Narz zu Pharmagest5
07.02.Equasens-Aktie steigt nach besser als erwarteten Umsatzzahlen im vierten Quartal4
07.02.Equasens stock rises on better-than-expected Q4 revenue7
06.02.Equasens: 2024 annual revenue321Villers-lès-Nancy, 6 February 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like) Revenue (€&)2023Reported...
► Artikel lesen
27.12.24Equasens: Strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons718Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software expert...
► Artikel lesen
07.11.24Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)874Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue: €158.2 million Return to growth in Q3 (+0.3%) Revenue (€m) 2023Reported basis...
► Artikel lesen
27.09.24Equasens: 2024 half-year results453Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing investment efforts in H1: Revenue:...
► Artikel lesen
02.08.24Equasens: H1 2024 revenue529Villers-lès-Nancy, 2 August 2024 - 6:00 p.m. (CET) PRESS RELEASE H1 2024 revenue: €108 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1